Projects per year
Personal profile
Education
- 2009 Ph.D., Graduate Institute of Clinical Medicine, Taipei Medical University
- 1985-1992 M.D., School of Medicine, National Taiwan University
Experience
- 2025.01- Superintendent,Taipei Cancer Center,Taipei Medical University
- 2023.04- Vice Superintendent, Taipei Medical University Hospital
- 2017.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2015.08- Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2021.08-2023.08 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2019.01-2023.04 Vice Superintendent, Taipei Medical University Hospital
- 2020.11-2021.07 Director, Department of Nuclear Medicine, Taipei Medical University Hospital
- 2016.06-2017.07 Deputy Director, School of Medicine, College of Medicine, Taipei Medical University
- 2015 Vice Chairman, Department of Surgery, Taipei Medical University Hospital
- 2015.08-2016.07 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2012.08-2015.07 Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.08-2012.07 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2008 Chief, Division of General Surgery, Taipei Medical University Hospital
- 2006 Attending Doctor, General Surgery, Taipei Medical University Hospital
- 2006.02-2009.07 Instructor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2005.12-2006.05 Director, Division of Rectal Surgery, Min-Sheng Hospital
- 2004.07-2005.11 Director, Division of General Surgery, En Chu Kong Hospital
- 2003.07-2004.06 Director, Division of Rectal Surgery, En Chu Kong Hospital
- 1997.07-2006.06 Attending Physician, Department of Surgery, En Chu Kong Hospital
- 1992.07-1997.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Awards
- 2015 Faculty Award of Taipei Medical University
- 2015 Distinguished Teaching Award of College of Medicine, Taipei Medical University
- 2013 Best Advisor Award of College of Medicine, Taipei Medical University
- 2011 The excellent thesis of the year 2010 by international college of surgeons
Research Interests
- Cancer molecular biology
- Signal transduction
- ER stress and metastasis
- Colorectal Surgery
Related Link
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Investigating the Role of Slc35d1 in Colorectal Cancer Progression and Chemoresistance
Wei, P.-L. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Investigate the Regulatory Mechanism and Therapeutic Roles of Msn in Colorectal Cancer (Continuation Project)
Wei, P.-L. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Investigate the Regulatory Mechanism and Therapeutic Roles of Msn in Colorectal Cancer
Wei, P.-L. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
探討PCTK1激?蛋白在大腸直腸癌發展的角色及其調控機制(延續計畫)(3/3)
Wei, P.-L. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(2/3)
Wei, P.-L. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T.-Y., van Hagen, T., Wei, P.-L., Day, F., Mehta, S. & Yau, T. & 10 others, , Mar 2025, In: The Lancet Gastroenterology and Hepatology. 10, 3, p. 198-209 12 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Correction to: Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling (Biomedicines, (2022), 10, 2, (377), 10.3390/biomedicines10020377)
Leung, W. H., Shih, J. W., Chen, J. S., Mokgautsi, N., Wei, P. L. & Huang, Y. J., Mar 2025, In: Biomedicines. 13, 3, 547.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Effectiveness of pudendal nerve block in the management of acute post-haemorrhoidectomy pain in Asian individuals using inverse probability of treatment weighting (IPTW)
Chen, C. C., Chang, K. T., Lee, Y. W., Chen, J. S., Wei, P. L., Chang, C. L. & Huang, Y. J., Jan 2025, In: Asian Journal of Surgery. 48, 1, p. 131-136 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Prehabilitation Interventions in Patients Undergoing Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis
Liao, Y. S., Chiu, H. Y., Huang, F. H., Chang, Y. H., Huang, Y. M., Wei, P. L., Wang, W., Hung, C. S. & Tung, H. H., 2025, (Accepted/In press) In: Journal of the American Geriatrics Society.Research output: Contribution to journal › Review article › peer-review
Open Access -
Diode laser hemorrhoidoplasty versus conventional Milligan-Morgan and Ferguson hemorrhoidectomy for symptomatic hemorrhoids: Meta-analysis
Cheng, P. L., Chen, C. C., Chen, J. S., Wei, P. L. & Huang, Y. J., Nov 2024, In: Asian Journal of Surgery. 47, 11, p. 4681-4690 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T.-T. (Contributor), Tzeng, Y.-M. (Contributor), Yen, Y. (Creator), Yang, C.-K. (Contributor), Wu, A. T. (Creator), Meng, T.-C. (Contributor), Whang-Peng, J. (Creator), Wei, P.-L. (Contributor), Hsiao, M. (Creator) & Huang, Y.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y.-J. (Contributor), Yang, C.-K. (Contributor), Wei, P.-L. (Contributor), Huynh, T.-T. (Contributor), Whang-Peng, J. (Creator), Meng, T.-C. (Contributor), Hsiao, M. (Creator), Tzeng, Y.-M. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
Dataset
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
HuangFu, W.-C. (Creator), Sung, T.-Y. (Creator), Lee, Y.-C. (Contributor), Pan, S.-L. (Creator), Cheng, Y.-W. (Creator), Chang, F.-L. (Creator), Wei, P.-L. (Contributor), Huang, C.-C. (Contributor), Huang, H.-L. (Contributor) & Cheng, C.-C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
Dataset
-
Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Tsai, H.-L. (Contributor), Sung, Y.-C. (Contributor), Tang, H.-C. (Contributor), Yeh, Y.-S. (Contributor), Wei, P.-L. (Contributor), Wang, J.-Y. (Contributor) & Huang, C.-W. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544_d1.v1
Dataset
-
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y.-S. (Contributor), Tsai, H.-L. (Contributor), Huang, C.-W. (Creator), Wei, P.-L. (Contributor), Sung, Y.-C. (Contributor), Tang, H.-C. (Contributor) & Wang, J.-Y. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544.v1
Dataset